"Neuraminidase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992)
Descriptor ID |
D009439
|
MeSH Number(s) |
D08.811.277.450.692
|
Concept/Terms |
Neuraminidase- Neuraminidase
- Exo-alpha-Sialidase
- Exo alpha Sialidase
- Sialidase
- N-Acylneuraminate Glycohydrolases
- Glycohydrolases, N-Acylneuraminate
- N Acylneuraminate Glycohydrolases
- Oligosaccharide Sialidase
- Sialidase, Oligosaccharide
|
Below are MeSH descriptors whose meaning is more general than "Neuraminidase".
Below are MeSH descriptors whose meaning is more specific than "Neuraminidase".
This graph shows the total number of publications written about "Neuraminidase" by people in this website by year, and whether "Neuraminidase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
1999 | 1 | 1 | 2 |
2000 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 1 | 1 | 2 |
2005 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2011 | 0 | 2 | 2 |
2012 | 1 | 1 | 2 |
2013 | 2 | 0 | 2 |
2014 | 0 | 2 | 2 |
2015 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuraminidase" by people in Profiles.
-
Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens. Brief Bioinform. 2022 03 10; 23(2).
-
Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus. Nat Commun. 2021 10 25; 12(1):6161.
-
Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model. J Virol. 2022 01 26; 96(2):e0142121.
-
Cardiovascular involvement in alpha-n-acetyl neuraminidase deficiency syndromes (sialidosis type I and II). Cardiol Young. 2021 May; 31(5):862-864.
-
Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice. Vaccine. 2020 10 21; 38(45):7129-7137.
-
Emerging from the Shadow of Hemagglutinin: Neuraminidase Is an Important Target for Influenza Vaccination. Cell Host Microbe. 2019 12 11; 26(6):712-713.
-
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain. Nat Microbiol. 2019 12; 4(12):2216-2225.
-
Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance. J Virol. 2019 02 15; 93(4).
-
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies. Cell. 2018 04 05; 173(2):417-429.e10.
-
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines? mBio. 2018 04 03; 9(2).